• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON PEN II MYLAN 3.0ML; PEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON PEN II MYLAN 3.0ML; PEN NEEDLE Back to Search Results
Catalog Number 47314378
Device Problem Failure to Deliver (2338)
Patient Problem Underdose (2542)
Event Date 02/21/2019
Event Type  malfunction  
Manufacturer Narrative
Investigation summary: the customer issued a complaint for dosing incomplete from pen detected during use of the product by the end-user.One (1) sample was provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Bdm-ps performed a batch history record¿s review (bhr) including a review of all data collected during in process and quality inspections.The batch involved in this complaint meets all acceptable quality levels (aql¿s), was manufactured and released according to applicable procedures and specifications.Initial evaluation revealed no visible damage to the pen.The pen was tested for volumetric dose accuracy per it1172.All doses were within specification, and the pen functioned as intended.An injection sequence was executed using a 29g x 12.7mm bd pen needle and cartridge.Investigation conclusion: based on investigation conclusion, bdm-ps was not able to confirm the symptom perceived by customer or correlate this symptom with a potential cause linked to bd process.Root cause description: based on investigation conclusion, bdm-ps was not able to confirm the symptom perceived by customer or correlate this symptom with a potential cause linked to bd process.Rationale: unconfirmed, no issue observed.Oem manufacture: the manufacturing location for this product is (b)(4).This site is an oem manufacturing site.
 
Event Description
It was reported that two pen ii mylan 3.0ml experienced an inability to deliver medication during use.The customer reported, "apokyn pen issues: pen doesn't administer medication completely and has to be readministered.This has happened with two pens, request for pen replacement prescription through the hub and md office.She stated this is not the first time this has happened and that sometimes the pens become defective after 2-3 months, and other times after one dose.The current defective pen she has is about 1 week old.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PEN II MYLAN 3.0ML
Type of Device
PEN NEEDLE
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652341
MDR Report Key8457773
MDR Text Key145249243
Report Number2243072-2019-00578
Device Sequence Number1
Product Code FMI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number47314378
Device Lot Number16218001
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-